New ICSF Report: Identifying replicable healthcare models with significant social benefit

Posted By on May 16, 2013 6:00 am

On behalf of GlaxoSmithKline (GSK), the ICSF has undertaken the first ever global in-depth study to identify healthcare innovations in developing countries that have the potential to be replicated to increase access to affordable medicine. The report assesses over 900 healthcare programmes for their suitability for investment to scale up and replicate elsewhere.  It identifies significant opportunities for commercial organisations to establish strategic partnerships with a number of promising healthcare delivery models in order to drive scale, profitability and impact.

Download the full report 

Download the press release

Articles and Blogs on the report

Image courtesy of Afrikids